TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Person-centered Follow up and Health Promotion Program After Revascularization for Intermittent Claudication
Brief Summary: The overall aim of the study is to evaluate a nurse-led intervention (person-centered follow up and health promotion) program in comparison to standard follow up for patients treated with surgical or endovascular revascularization of Intermittent Claudication.


Options:
A: Arm Label: Person-centered follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Person-centered follow up | Arm Label: Standard follow up; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Person-centered follow up; Assigned to Arm(s): Person-centered follow up
B: Arm Label: Cilostazol + L-Carnitine; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Levocarnitine tartrate, Drug: cilostazol | Arm Label: Cilostazol + Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: cilostazol | Intervention Type: DIETARY_SUPPLEMENT; Name: Levocarnitine tartrate; Assigned to Arm(s): Cilostazol + L-Carnitine | Intervention Type: DRUG; Name: cilostazol; Assigned to Arm(s): Cilostazol + L-Carnitine, Cilostazol + Placebo
C: Arm Label: low dose K-134; Type: EXPERIMENTAL; Interventions: Drug: K-134 | Arm Label: mid dose K-134; Type: EXPERIMENTAL; Interventions: Drug: K-134 | Arm Label: high dose K-134; Type: EXPERIMENTAL; Interventions: Drug: K-134 | Arm Label: Comparator; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cilostazol 100 mg BID | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: K-134; Assigned to Arm(s): high dose K-134, low dose K-134, mid dose K-134 | Intervention Type: DRUG; Name: Cilostazol 100 mg BID; Assigned to Arm(s): Comparator | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Cilostazol; Type: EXPERIMENTAL; Interventions: Drug: cilostazol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: cilostazol; Assigned to Arm(s): Cilostazol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Physical Exercise for Education ('Fit to Study')
Brief Summary: Neuroscience evidence suggests that physical exercise can influence brain function and structure, both immediately and in the long-term. The 'Fit to Study' project is a randomised controlled trial to test the effects on academic performance (as well as fitness, wellbeing and cognitive function) of a teacher-training intervention designed to optimise the content of PE for brain and cognitive function during secondary school (Year 8) Physical Education (PE) lessons. The project aims to rigorously test the impact of this intervention in 100 state-funded secondary schools.


Options:
A: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Education (PE) Programme | Intervention Type: BEHAVIORAL; Name: Physical Education (PE) Programme; Assigned to Arm(s): Intervention Group
B: Arm Label: A Healthy School Start Plus intervention; Type: EXPERIMENTAL; Interventions: Behavioral: A Healthy School Start Plus intervention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: A Healthy School Start Plus intervention | Intervention Type: BEHAVIORAL; Name: A Healthy School Start Plus intervention; Assigned to Arm(s): A Healthy School Start Plus intervention, Control
C: Arm Label: Normal math; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active math; Type: EXPERIMENTAL; Interventions: Behavioral: Physically active math lessons | Intervention Type: BEHAVIORAL; Name: Physically active math lessons; Assigned to Arm(s): Active math
D: Arm Label: Program SI! for Elementary 6 levels; Type: EXPERIMENTAL; Interventions: Behavioral: PSIE13, Behavioral: PSIE46 | Arm Label: Normal curriculum; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Program SI! for Elementary first levels; Type: EXPERIMENTAL; Interventions: Behavioral: PSIE13 | Arm Label: Program SI! for Elementary last levels; Type: EXPERIMENTAL; Interventions: Behavioral: PSIE46 | Intervention Type: BEHAVIORAL; Name: PSIE13; Assigned to Arm(s): Program SI! for Elementary 6 levels, Program SI! for Elementary first levels | Intervention Type: BEHAVIORAL; Name: PSIE46; Assigned to Arm(s): Program SI! for Elementary 6 levels, Program SI! for Elementary last levels

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Single Arm, Open-label, Multi-centre, Phase I/II Study Evaluating the Safety and Clinical Activity of AUTO3, a CAR T Cell Treatment Targeting CD19 and CD22 With Anti PD1 Antibody in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Brief Summary: The purpose of this study is to test the safety and efficacy of AUTO3, a CAR T cell treatment targeting CD19 and CD22 followed by limited duration of anti-PD1 antibody in patients with DLBCL


Options:
A: Arm Label: AUTO3; Type: EXPERIMENTAL; Interventions: Biological: AUTO3 | Intervention Type: BIOLOGICAL; Name: AUTO3; Assigned to Arm(s): AUTO3
B: Arm Label: C-CAR011; Type: EXPERIMENTAL; Interventions: Biological: C-CAR-011 | Intervention Type: BIOLOGICAL; Name: C-CAR-011; Assigned to Arm(s): C-CAR011
C: Arm Label: 1A/T cell Arm (closed); Type: EXPERIMENTAL; Interventions: Procedure: Allogeneic stem cell transplant, Biological: Anti-CD19-chimeric-antigen-receptor-transduced T cells | Arm Label: 1B/T memory stem cell arm; Type: EXPERIMENTAL; Interventions: Procedure: Allogeneic stem cell transplant, Biological: Anti-CD19-chimeric-antigen-receptor-transduced T cells | Arm Label: 2/Donor arm; Type: OTHER; Interventions: Procedure: Leukapheresis | Intervention Type: PROCEDURE; Name: Allogeneic stem cell transplant; Assigned to Arm(s): 1A/T cell Arm (closed), 1B/T memory stem cell arm | Intervention Type: BIOLOGICAL; Name: Anti-CD19-chimeric-antigen-receptor-transduced T cells; Assigned to Arm(s): 1A/T cell Arm (closed), 1B/T memory stem cell arm | Intervention Type: PROCEDURE; Name: Leukapheresis; Assigned to Arm(s): 2/Donor arm
D: Arm Label: JWCAR029; Type: EXPERIMENTAL; Interventions: Biological: JWCAR029 | Intervention Type: BIOLOGICAL; Name: JWCAR029; Assigned to Arm(s): JWCAR029

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does the Use of Liposomal Bupivacaine Decrease Narcotic Requirements in Geriatric Hip Fractures? A Randomized, Double Blinded Control Trial
Brief Summary: This is a prospective, randomized study looking at the effect that a long-acting local anesthetic has on pain control in patients having surgery for hip fractures. The investigators are conducting the study to see if that reduces the amount of pain medicine needed after surgery, and if it reduces other medical complications after surgery.


Options:
A: Arm Label: regional anesthesia; Type: N/A; Interventions: N/A | Arm Label: systemic analgesia; Type: N/A; Interventions: N/A
B: Arm Label: Fascia iliaca block; Type: EXPERIMENTAL; Interventions: Procedure: Fascia iliaca block | Arm Label: Sham injection; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham injection | Intervention Type: PROCEDURE; Name: Fascia iliaca block; Assigned to Arm(s): Fascia iliaca block | Intervention Type: PROCEDURE; Name: Sham injection; Assigned to Arm(s): Sham injection
C: Arm Label: Exparel (Liposomal Bupivacaine); Type: EXPERIMENTAL; Interventions: Drug: Exparel | Arm Label: Saline Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride | Intervention Type: DRUG; Name: Exparel; Assigned to Arm(s): Exparel (Liposomal Bupivacaine) | Intervention Type: DRUG; Name: Sodium Chloride; Assigned to Arm(s): Saline Control
D: Arm Label: Ropivacaine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ropivacaine | Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ropivacaine | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Ropivacaine, Saline

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Combined Use of Contact Aspiration and the Stent Retriever Technique Versus Stent Retriever Alone for Recanalisation in Acute Cerebral Infarction: the Randomized ASTER2 Study
Brief Summary: Mechanical thrombectomy (MT) with a stent retriever (SR) device is now the standard intervention in ischemic stroke with large vessel occlusion. Favorable outcome is strongly associated with the successful reperfusion status. New device of MT such as contact aspiration seems promising to increase reperfusion status and clinical outcome.

The main hypothesis is to show the superiority of combining the use of contact aspiration with a stent retriever compared to a stent retriever alone in treatment of acute stroke due to proximal arterial occlusion.

The primary endpoint is the rate of perfect reperfusion score at the end of the endovascular procedure.


Options:
A: Arm Label: IV t-PA with Solitaire™ revascularization device; Type: EXPERIMENTAL; Interventions: Device: Solitaire revascularization device | Arm Label: IV t-PA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous (IV) recombinant human tissue plasminogen activator (rtPA) | Intervention Type: DRUG; Name: Intravenous (IV) recombinant human tissue plasminogen activator (rtPA); Assigned to Arm(s): IV t-PA | Intervention Type: DEVICE; Name: Solitaire revascularization device; Assigned to Arm(s): IV t-PA with Solitaire™ revascularization device
B: Arm Label: Combined use of contact aspiration and stent retriever; Type: EXPERIMENTAL; Interventions: Combination Product: Combined contact aspiration/Stent Retriever Technique | Arm Label: Stent retriever mechanical thrombectomy alone; Type: ACTIVE_COMPARATOR; Interventions: Device: Stent retriever technique | Intervention Type: COMBINATION_PRODUCT; Name: Combined contact aspiration/Stent Retriever Technique; Assigned to Arm(s): Combined use of contact aspiration and stent retriever | Intervention Type: DEVICE; Name: Stent retriever technique; Assigned to Arm(s): Stent retriever mechanical thrombectomy alone
C: Arm Label: ADAPT; Type: EXPERIMENTAL; Interventions: Procedure: direct aspiration procedure | Arm Label: Stent Retriever; Type: ACTIVE_COMPARATOR; Interventions: Procedure: stent retriever procedure | Intervention Type: PROCEDURE; Name: direct aspiration procedure; Assigned to Arm(s): ADAPT | Intervention Type: PROCEDURE; Name: stent retriever procedure; Assigned to Arm(s): Stent Retriever
D: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach
Brief Summary: This study assesses the effect of a low-dose, high-frequency training approach on long-term evidence-based skill retention among skilled birth attendants and impact on adverse birth outcomes at hospitals in Ghana.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Low dose high frequency health worker training approach | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparison | Intervention Type: BEHAVIORAL; Name: Low dose high frequency health worker training approach; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Active Comparison; Assigned to Arm(s): Comparison
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PRONTO training; Type: EXPERIMENTAL; Interventions: Other: PRONTO training | Intervention Type: OTHER; Name: PRONTO training; Assigned to Arm(s): PRONTO training
C: Arm Label: In situ simulation; Type: EXPERIMENTAL; Interventions: Other: In situ simulation | Arm Label: Off site simulation; Type: ACTIVE_COMPARATOR; Interventions: Other: Off site simulation | Intervention Type: OTHER; Name: In situ simulation; Assigned to Arm(s): In situ simulation | Intervention Type: OTHER; Name: Off site simulation; Assigned to Arm(s): Off site simulation
D: Arm Label: package; Type: EXPERIMENTAL; Interventions: Other: package of 3 interventions | Intervention Type: OTHER; Name: package of 3 interventions; Assigned to Arm(s): package

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach
Brief Summary: This study assesses the effect of a low-dose, high-frequency training approach on long-term evidence-based skill retention among skilled birth attendants and impact on adverse birth outcomes at hospitals in Ghana.


Options:
A: Arm Label: In situ simulation; Type: EXPERIMENTAL; Interventions: Other: In situ simulation | Arm Label: Off site simulation; Type: ACTIVE_COMPARATOR; Interventions: Other: Off site simulation | Intervention Type: OTHER; Name: In situ simulation; Assigned to Arm(s): In situ simulation | Intervention Type: OTHER; Name: Off site simulation; Assigned to Arm(s): Off site simulation
B: Arm Label: NRP Training (Intervention); Type: EXPERIMENTAL; Interventions: Procedure: Neonatal Resuscitation | Arm Label: Control; Type: OTHER; Interventions: Procedure: Neonatal Resuscitation | Intervention Type: PROCEDURE; Name: Neonatal Resuscitation; Assigned to Arm(s): Control, NRP Training (Intervention)
C: Arm Label: EMONC: Community mobilization, HBLSS and Facility Improvement; Type: EXPERIMENTAL; Interventions: Behavioral: Community Mobilization, HBLSS and facility improvement | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Community Mobilization, HBLSS and facility improvement; Assigned to Arm(s): EMONC: Community mobilization, HBLSS and Facility Improvement
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Low dose high frequency health worker training approach | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparison | Intervention Type: BEHAVIORAL; Name: Low dose high frequency health worker training approach; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Active Comparison; Assigned to Arm(s): Comparison

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial to Identify the Effect and the Working Mechanisms of MyPlan 2.0, a Self-regulation-based e- and mHealth Intervention Targeting Physical Activity and Sedentary Behaviour, in Adults With Type 2 Diabetes.
Brief Summary: The aim of this study is to investigate whether and how 'MyPlan 2.0' helps adults with type 2 diabetes to be more physically active or less sedentary. Two groups will be created, an intervention group and a waiting-list control group.


Options:
A: Arm Label: FlexToBa physical activity DVD; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based, DVD-delivered physical activity | Arm Label: Usual care-Wait list; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care/Wait list | Intervention Type: BEHAVIORAL; Name: Home-based, DVD-delivered physical activity; Assigned to Arm(s): FlexToBa physical activity DVD | Intervention Type: BEHAVIORAL; Name: Usual care/Wait list; Assigned to Arm(s): Usual care-Wait list
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: Behavioral: website assess | Intervention Type: BEHAVIORAL; Name: website assess; Assigned to Arm(s): Control group
C: Arm Label: Wait list control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Monitor intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Monitor intervention | Intervention Type: BEHAVIORAL; Name: Monitor intervention; Assigned to Arm(s): Monitor intervention
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: MyPlan 2.0 | Arm Label: Waiting-list control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MyPlan 2.0; Assigned to Arm(s): Intervention group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparing the Benefits of Functional Recovery Between the Early Mobilization and Early Conventional Intervention After Stroke for the Patients With Mild to Moderate Hemorrhagic Stroke
Brief Summary: This study aims to examine the outcomes of early mobilization and early intervention within 24-72 hours after the onset of hemorrhagic stroke in patients admitted to an intensive care unit within 24 hours after stroke. The patients after hemorrhagic stroke who undergo early intervention only will be compared with those who also receive early mobilization in order to determine if the early mobilization intervention results in earlier or more effective recovery of postural stability, activities of daily living function, or motor capacity.

The participants will be randomly assigned to the following two groups: (1) the early mobilization (+early rehabilitation) group and (2) the early rehabilitation group.The measurement parameters will be collected before the intervention (basic parameters), two weeks after the stroke, four weeks after the stroke and three months after the stroke. SPSS (version 17.0) will be used to carry out repeated measures analysis of variance (repeated ANOVA) to compare the differences between the groups at different time points (including basic values and follow-up values). For statistical significance, Bonferroni correction will be applied for the post-hoc analysis of the groups.


Options:
A: Arm Label: m-health stroke rehabilitation; Type: N/A; Interventions: Behavioral: Multimodal Exercise Rehabilitation Program | Intervention Type: BEHAVIORAL; Name: Multimodal Exercise Rehabilitation Program; Assigned to Arm(s): m-health stroke rehabilitation
B: Arm Label: STUFFS; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behaviour intervention | Intervention Type: BEHAVIORAL; Name: Sedentary behaviour intervention; Assigned to Arm(s): STUFFS
C: Arm Label: early mobilization; Type: EXPERIMENTAL; Interventions: Behavioral: early mobilization | Arm Label: early standard intervention; Type: OTHER; Interventions: Behavioral: early standard intervention | Intervention Type: BEHAVIORAL; Name: early mobilization; Assigned to Arm(s): early mobilization | Intervention Type: BEHAVIORAL; Name: early standard intervention; Assigned to Arm(s): early standard intervention
D: Arm Label: Rehabilitation training; Type: EXPERIMENTAL; Interventions: Other: Rehabilitation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Rehabilitation; Assigned to Arm(s): Rehabilitation training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Socio-health Impact of a Multifactorial Program of Hand Hygiene on Respiratory and Gastrointestinal Infections in Children Attending in Day-care Centres
Brief Summary: It is well known that attending Day Care Centres (DCCs) can lead to an increase in the frequency of infections, due to the high incidence at this age and also the ease of transmission among children. This high incidence respiratory tract infections (RTIs) and acute gastroenteritis can also have a significant impact on the cost of health care systems, increasing the number of medical visits, hospitalizations and prescribing medications as symptomatic drugs or unnecessary antibiotics in some cases.The aim of the study was to determine whether a multifactorial hand-hygiene program (handwashing with soap and water vs hand sanitizer vs control group) reduce episodes due to RTIs and gastroenteritis in children attending DCCs. In addition, analyze the cost-effectiveness of these interventions.


Options:
A: Arm Label: Hand sanitizer group; Type: EXPERIMENTAL; Interventions: Other: hand sanitizer | Arm Label: Liquid soap group; Type: EXPERIMENTAL; Interventions: Other: liquid soap | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: hand sanitizer; Assigned to Arm(s): Hand sanitizer group | Intervention Type: OTHER; Name: liquid soap; Assigned to Arm(s): Liquid soap group
B: Intervention Type: PROCEDURE; Name: Laparotomy+ HIPEC +/- CRS; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: GB (Florestor) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: GRALB | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: GC (placebo) | Intervention Type: DRUG; Name: GB (Florestor); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: GRALB; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: GC (placebo); Assigned to Arm(s): 3
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Soap | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Soap; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Pan-Asian Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology Programme
Brief Summary: To demonstrate non-inferiority of FE 999049 compared with GONAL-F with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Intervention Type: DRUG; Name: Follitropin Delta (FE 999049); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Follitropin Alfa (GONAL-F); Assigned to Arm(s): B
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Intervention Type: DRUG; Name: Follitropin Delta (FE 999049); Assigned to Arm(s): A, C | Intervention Type: DRUG; Name: Follitropin Alfa (GONAL-F); Assigned to Arm(s): B, D
C: Arm Label: Follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: Follitropin delta | Arm Label: Gonal-F; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin alfa | Intervention Type: DRUG; Name: Follitropin alfa; Assigned to Arm(s): Gonal-F | Intervention Type: DRUG; Name: Follitropin delta; Assigned to Arm(s): Follitropin delta
D: Arm Label: Highly Purified Menotrophin; Type: EXPERIMENTAL; Interventions: Drug: Highly purified menotrophin | Arm Label: Recombinant FSH; Type: ACTIVE_COMPARATOR; Interventions: Drug: Recombinant FSH | Intervention Type: DRUG; Name: Highly purified menotrophin; Assigned to Arm(s): Highly Purified Menotrophin | Intervention Type: DRUG; Name: Recombinant FSH; Assigned to Arm(s): Recombinant FSH

Answer: C